Climbing STAIRs towards clinical trials with a novel PARP-1 inhibitor for the treatment of ischemic stroke

Brain Research

Volumn 1410, Issue , 2011, Pages 120-121

  Ford, Andria L ^a   Lee, Jin Moo ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MP 124; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BRAIN ISCHEMIA; BREAST CANCER; CLINICAL TRIAL (TOPIC); DNA REPAIR; HEART INFARCTION; HUMAN; NEOPLASM; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL;

BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; ENZYME INHIBITORS; HUMANS; POLY(ADP-RIBOSE) POLYMERASES; STROKE;

EID: 80052022360     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.07.001     Document Type: Article

References (17)

1. Y. Egi, S. Matsuura, T. Maruyama, M. Fujio, S. Yuki, and T. Akira Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia Brain Res 1389 2011 169 176
2. M.J. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J. Traystman, J. Bao, A. Pieper, Z.Q. Wang, T.M. Dawson, S.H. Snyder, and V.L. Dawson Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat Med 3 10 1997 1089 1095 (Pubitemid 27444449)
3. M. Endres, Z.Q. Wang, S. Namura, C. Waeber, and M.A. Moskowitz Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase J Cereb Blood Flow Metab 17 11 1997 1143 1151 (Pubitemid 27514738)
4. D.V. Ferraris Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic J Med Chem 53 12 2010 4561 4584
5. M. Fisher, G. Feuerstein, D.W. Howells, P.D. Hurn, T.A. Kent, S.I. Savitz, and E.H. Lo Update of the stroke therapy academic industry roundtable preclinical recommendations Stroke 40 6 2009 2244 2250
6. G. Graziani, and C. Szabo Clinical perspectives of PARP inhibitors Pharmacol. Res. 52 1 2005 109 118 (Pubitemid 40725605)
7. J.W. Marshall, K.J. Duffin, A.R. Green, and R.M. Ridley NXY-059, a free radical-trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species Stroke 32 1 2001 190 198 (Pubitemid 32063845)
8. J.W. Marshall, R.M. Cummings, L.J. Bowes, R.M. Ridley, and A.R. Green Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion Stroke 34 9 2003 2228 2233 (Pubitemid 37099841)
9. Matsuura, S., Egi, Y., Yuki, S., Satoh, H., Akira, T., in press. MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates the ischemic brain damage in non-human primate model. Brain Res.
10. L.D. McCullough, Z. Zeng, K.K. Blizzard, I. Debchoudhury, and P.D. Hurn Ischemic nitric oxide and poly(ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection J Cereb Blood Flow Metab 25 4 2005 502 512
11. P. Pacher, and C. Szabo Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease Am. J. Pathol. 173 1 2008 2 13 (Pubitemid 351947950)
12. S.I. Savitz A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke Exp. Neurol. 205 1 2007 20 25 (Pubitemid 46621180)
13. A. Shuaib, K.R. Lees, P. Lyden, J. Grotta, A. Davalos, S.M. Davis, H.C. Diener, T. Ashwood, W.W. Wasiewski, and U. Emeribe NXY-059 for the treatment of acute ischemic stroke N Engl J Med 357 6 2007 562 571 (Pubitemid 47236281)
14. Stroke Therapy Academic Industry Roundtable Recommendations for standards regarding preclinical neuroprotective and restorative drug development Stroke 30 12 1999 2752 2758
15. Stroke Therapy Academic Industry Roundtable Recommendations for clinical trial evaluation of acute stroke therapies Stroke 32 7 2001 1598 1606
16. C. Szabo, and V.L. Dawson Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion Trends Pharmacol Sci 19 7 1998 287 298 (Pubitemid 28358088)
17. C. Szabo, L.H. Lim, S. Cuzzocrea, S.J. Getting, B. Zingarelli, R.J. Flower, A.L. Salzman, and M. Perretti Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects J Exp Med 186 7 1997 1041 1049 (Pubitemid 27441148)